Submitted:
26 September 2024
Posted:
27 September 2024
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Materials and Methods
- Participants or population: We included all studies with lay participants (e.g., patients, students, citizens). Studies targeting only healthcare providers were excluded.
- Interventions or phenomena of interest: We included all interactive conversational agents, i.e., those that involve a two-way exchange (written, oral or visual dialogue), aimed at laypeople for smoking or vaping cessation.
- Comparator: We did not apply any restrictions.
- Outcomes: We considered all outcomes reported in the trials. We looked for outcomes related to cigarette and e-cigarette smokers. These outcomes included barriers, facilitators, acceptability, feasibility, adoption, compliance, motivation to quit, abstinence rates, quit rates, smoking/ vaping-related disease morbidity, quality of life, satisfaction, cost and cost-effectiveness.
- Setting: We included trials conducted in all settings. All study types were included (qualitative, quantitative and mixed methods).
3. Results
3.1. Overview
3.2. Outcomes Measured
3.3. Methodological Quality Assessment
4. Discussion
4.1. Key Findings
4.2. Main Contributions
4.3. Strengths and Limitations
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Conflicts of Interest
Appendix A. Database Search Strategy
| # | Search strategy | Results |
| 1 | (“chat bot?” or chatterbot? or chatbot? or medbot? or “chatter bot?” or smart bot? or smartbot?).ti,ab,kw | 526 |
| 2 | (Conversational adj2 (host or coach or avatar or advisor or assistant or interface or avatar or agent? or system or computer or humanoid or character or bot? or AI)).ti,ab | 355 |
| 3 | ((virtual or intelligent or chat or computer or AI or “artificial intelligence” or relational or embodied) adj2 agent?).ti,ab | 938 |
| 4 | 1 or 2 or 3 | 1582 |
| 5 | exp Smoking/ OR Tobacco Use Disorder/ OR exp “Tobacco Use Disorder”/ OR Electronic Nicotine Delivery Systems/ OR Smoking Cessation/ OR “Tobacco Use Cessation”/ | 181214 |
| 6 | (Smoking OR Smoker? OR Tobacco OR Nicotine OR Cigarette? OR Vape* OR Vaping? OR Ecigarette? OR ECig OR “E-Cig”).ti,ab,kw,kf | 384819 |
| 7 | 5 OR 6 | 419866 |
| 8 | 4 AND 7 | 18 |
| 9 | limit 8 to ed=20210723-20220721 | 3 |
| # | Search strategy | Results |
| 1 | (“chat bot$” OR chatterbot$ OR chatbot$ OR medbot$ OR “chatter bot$” OR “smart bot$” OR smartbot$):ti,ab,kw | 507 |
| 2 | (Conversational NEAR/2 (host OR coach OR avatar OR advisor OR assistant OR interface OR avatar OR agent$ OR system OR computer OR humanoid OR character OR bot$ OR AI)):ti,ab | 324 |
| 3 | ((virtual OR intelligent OR chat OR computer OR AI OR “artificial intelligence” OR relational OR embodied) NEAR/2 agent$):ti,ab | 964 |
| 4 | #1 OR #2 OR #3 | 1,612 |
| 5 | ‘smoking’/exp OR ‘tobacco dependence’/de OR ‘tobacco use’/exp OR ‘smoking cessation’/de OR ‘electronic cigarette’/de | 499,263 |
| 6 | (Smoking OR Smoker$ OR Tobacco OR Nicotine OR Cigarette$ OR Vape* OR Vaping$ OR Ecigarette$ OR ECig OR “E-Cig”):ti,ab,kw | 549,408 |
| 7 | #5 OR #6 | 670,935 |
| 8 | #4 AND #7 | 24 |
| 9 | #8 AND [23-07-2021]/sd | 9 |
| # | Search strategy | Results |
| 1 | TI (“chat bot?” OR chatterbot? OR chatbot? OR medbot? OR “chatter bot?” OR smart bot? OR smartbot?) OR AB (“chat bot?” OR chatterbot? OR chatbot? OR medbot? OR “chatter bot?” OR smart bot? OR smartbot?) | 281 |
| 2 | TI (Conversational N2 (host OR coach OR avatar OR advisor OR assistant OR interface OR avatar OR agent? OR system OR computer OR humanoid OR character OR bot? OR AI)) OR AB (Conversational N2 (host OR coach OR avatar OR advisor OR assistant OR interface OR avatar OR agent? OR system OR computer OR humanoid OR character OR bot? OR AI)) | 188 |
| 3 | TI ((virtual OR intelligent OR chat OR computer OR AI OR “artificial intelligence” OR relational OR embodied) N2 agent?) OR AB ((virtual OR intelligent OR chat OR computer OR AI OR “artificial intelligence” OR relational OR embodied) N2 agent?) | 300 |
| 4 | S1 OR S2 OR S3 | 658 |
| 5 | MH “Smoking+” OR MH “Electronic Cigarettes” | 78,928 |
| 6 | TI (Smoking OR Smoker# OR Tobacco OR Nicotine OR Cigarette# OR Vape* OR Vaping# OR Ecigarette# OR ECig OR “E-Cig”) OR AB (Smoking OR Smoker# OR Tobacco OR Nicotine OR Cigarette# OR Vape* OR Vaping# OR Ecigarette# OR ECig OR “E-Cig”) | 122,238 |
| 7 | S5 OR S6 | 142,303 |
| 8 | S4 AND S7 | 7 |
| 9 | S8 AND DT 20210723-20220721 | 1 |
| # | Search strategy | Results |
| 1 | TS=(“chat bot$” OR chatterbot$ OR chatbot$ OR medbot$ OR “chatter bot$” OR smart bot$ OR smartbot$) | 40,548 |
| 2 | TS=(Conversational NEAR/2 (host OR coach OR avatar OR advisor OR assistant OR interface OR avatar OR agent$ OR system OR computer OR humanoid OR character OR bot$ OR AI)) | 3,878 |
| 3 | TS=((virtual OR intelligent OR chat OR computer OR AI OR “artificial intelligence” OR relational OR embodied) NEAR/2 agent$) | 16,274 |
| 4 | #1 OR #2 OR #3 | 58,623 |
| 5 | TS=(Smoking OR Smoker$ OR Tobacco OR Nicotine OR Cigarette$ OR Vape* OR Vaping$ OR Ecigarette$ OR ECig OR “E-Cig”) | 526,665 |
| 6 | #4 AND #5 | 130 |
| 7 | Database publications date limit from 2021-07-23 to 2022-07-21 | 22 |
| # | Search strategy | Results |
| 1 | chatbots WN CV | 555 |
| 2 | “chat bot*” WN TI OR chatterbot* WN TI OR chatbot* WN TI OR medbot* WN TI OR “chatter bot*” WN TI OR smart bot* WN TI OR smartbot* WN TI OR “chat bot*” WN AU OR chatterbot* WN AU OR chatbot* WN AU OR medbot* WN AU OR “chatter bot*” WN AU OR smart bot* WN AU OR smartbot* WN AU | 1,306 |
| 3 | (Conversational NEAR/2 host) WN TI OR (Conversational NEAR/2 coach) WN TI OR (Conversational NEAR/2 avatar) WN TI OR (Conversational NEAR/2 advisor) WN TI OR (Conversational NEAR/2 assistant) WN TI OR (Conversational NEAR/2 interface) WN TI OR (Conversational NEAR/2 avatar) WN TI OR (Conversational NEAR/2 agent*) WN TI OR (Conversational NEAR/2 system) WN TI OR (Conversational NEAR/2 computer) WN TI OR (Conversational NEAR/2 humanoid) WN TI OR (Conversational NEAR/2 character) WN TI OR (Conversational NEAR/2 bot*) WN TI OR (Conversational NEAR/2 AI) WN TI OR (Conversational NEAR/2 host) WN AU OR (Conversational NEAR/2 coach) WN AU OR (Conversational NEAR/2 avatar) WN AU OR (Conversational NEAR/2 advisor) WN AU OR (Conversational NEAR/2 assistant) WN AU OR (Conversational NEAR/2 interface) WN AU OR (Conversational NEAR/2 avatar) WN AU OR (Conversational NEAR/2 agent*) WN AU OR (Conversational NEAR/2 system) WN AU OR (Conversational NEAR/2 computer) WN AU OR (Conversational NEAR/2 humanoid) WN AU OR (Conversational NEAR/2 character) WN AU OR (Conversational NEAR/2 bot*) WN AU OR (Conversational NEAR/2 AI) WN AU | 1,065 |
| 4 | (virtual NEAR/2 agent) WN TI OR (intelligent NEAR/2 agent) WN TI OR (chat NEAR/2 agent) WN TI OR (computer NEAR/2 agent) WN TI OR (AI NEAR/2 agent) WN TI OR (“artificial intelligence” NEAR/2 agent) WN TI OR (relational NEAR/2 agent) WN TI OR (embodied NEAR/2 agent) WN TI OR (virtual NEAR/2 agent) WN AU OR (intelligent NEAR/2 agent) WN AU OR (chat NEAR/2 agent) WN AU OR (computer NEAR/2 agent) WN AU OR (AI NEAR/2 agent) WN AU OR (“artificial intelligence” NEAR/2 agent) WN AU OR (relational NEAR/2 agent) WN AU OR (embodied NEAR/2 agent) WN AU | 2,075 |
| 5 | #1 OR #2 OR #3 OR #4 | 4,505 |
| 6 | Tobacco WN CV OR Nicotine WN CV | 4,392 |
| 7 | Smoking WN TI OR Smoker* WN TI OR Tobacco WN TI OR Nicotine WN TI OR Cigarette* WN TI OR Vape* WN TI OR Vaping* WN TI OR Ecigarette* WN TI OR ECig WN TI OR “E-Cig” WN TI OR Smoking WN AB OR Smoker* WN AB OR Tobacco WN AB OR Nicotine WN AB OR Cigarette* WN AB OR Vape* WN AB OR Vaping* WN AB OR Ecigarette* WN AB OR ECig WN AB OR “E-Cig” WN AB | 11,204 |
| 8 | #6 OR #7 | 11,433 |
| 9 | #5 AND #8 | 3 |
| 10 | Database publications years limit from 2021 to 2022 | 0 |
References
- Global Burden of Disease (database). Washington, DC: Institute of Health Metrics; 2019. IHME, accessed 17 July 2024.
- Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health. How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease: A Report of the Surgeon General. Atlanta: Centers for Disease Control and Prevention; 2010. https://scholar-google-com.acces.bibl.ulaval.ca/scholar_lookup?title=How+Tobacco+Smoke+Causes+Disease:+The+Biology+and+Behavioral+Basis+for+Smoking-Attributable+Disease:+A+Report+of+the+Surgeon+General&publication_year=2010&.
- United States Public Health Service, Office of the Surgeon General, Office on Smoking and Health. The Health Consequences of Smoking: A Report of the Surgeon General. Rockville, MD: US Department of Health and Human Services, Public Health Service; 2004. https://scholar-google-com.acces.bibl.ulaval.ca/scholar_lookup?title=The+Health+Consequences+of+Smoking:+A+Report+of+the+Surgeon+General&publication_year=2004&.
- Tammemägi, M. C., Berg, C. D., Riley, T. L., Cunningham, C. R., & Taylor, K. L. (2014). Impact of lung cancer screening results on smoking cessation. Journal of the National Cancer Institute, 106(6), dju084. [CrossRef]
- Tehrani, H., Rajabi, A., Ghelichi- Ghojogh, M. et al. (2022). The prevalence of electronic cigarettes vaping globally: a systematic review and meta-analysis. Arch Public Health 2022. 80, 240 . [CrossRef]
- Fadus, M. C., Smith, T. T., & Squeglia, L. M. (2019). The rise of e-cigarettes, pod mod devices, and JUUL among youth: Factors influencing use, health implications, and downstream effects. Drug and alcohol dependence, 201, 85–93. [CrossRef]
- Jerzyński, T., Stimson. G. V. (2023). Estimation of the global number of vapers: 82 million worldwide in 2021. Drugs Habits Soc Policy;24(2):91-103. [CrossRef]
- World Health Organization. World Health Organization. 2024. Tobacco and nicotine industry tactics addict youth for life. Disponible sur: https://www.who.int/news/item/23-05-2024-tobacco-and-nicotine-industry-tactics-addict-youth-for-life.
- Stephan, Y., Sutin, A. R., Luchetti, M., Caille, P., & Terracciano, A. (2019). Cigarette smoking and personality change across adulthood: Findings from five longitudinal samples. Journal of Research in Personality, 81, 187-194. [CrossRef]
- US Department of Health and Human Services. (2016). E-cigarette use among youth and young adults: A report of the Surgeon General.
- Goriounova, N. A., & Mansvelder, H. D. (2012). Short-and long-term consequences of nicotine exposure during adoles-cence for prefrontal cortex neuronal network function. Cold Spring Harbor perspectives in medicine, 2(12), a012120.
- Bonilla, A., Blair, A. J., Alamro, S. M., Ward, R. A., Feldman, M. B., Dutko, R. A., ... & Vyas, J. M. (2019). Recurrent spontaneous pneumothoraces and vaping in an 18-year-old man: a case report and review of the literature. Journal of Medical Case Reports, 13(1), 1-6. [CrossRef]
- Johns Hopkins Medicine. (2022). What Does Vaping Do to Your Lungs? Johns Hopkins Medicine. https://www.hopkinsmedicine.org/health/wellness-and-prevention/what-does-vapingdo-to-your-lungs.
- Canadian Cancer Society. (2020). Risk factors for lung cancer. Retrieved 2022, from https://cancer.ca/en/cancer-information/cancer-types/lung/risks#:~:text=About%2072%25%20of%20lung%20cancer,and%20have%20other%20risk%20factors.
- Alami H, Fortin JP, Gagnon MP, Lamothe L, Ghandour EK, Ag Ahmed MA, Roy D. Cadre stratégique pour soutenir l’évaluation des projets complexes et innovants en santé numérique. Sante Publique. 2020;32(2):221-228. French. PMID: 35724215. [CrossRef]
- Berg, C. J., Romm, K. F., Patterson, B., Wysota, C., & Abroms, L. C. (2021). Appeal of novel cessation intervention ap-proaches among young-adult users of traditional and alternative tobacco products. Tobacco use insights, 14, 1179173X211041123. [CrossRef]
- Graham, A. L., Amato, M. S., Cha, S., Jacobs, M. A., Bottcher, M. M., & Papandonatos, G. D. (2021). Effectiveness of a Vaping Cessation Text Message Program Among Young Adult e-Cigarette Users: A Randomized Clinical Trial. JAMA in-ternal medicine. [CrossRef]
- Denecke K, Tschanz M, Dorner TL, May R. (2019). Intelligent conversational agents in healthcare: hype or hope? Stud Health Technol Inform;259:77-84. (Medline: 30923277). [CrossRef]
- Montenegro JLZ, da Costa CA, da Rosa Righi R. Survey of conversational agents in health. Expert Syst Appl 2019 Sep;129:56-67. [CrossRef]
- Tudor Car L, Dhinagaran DA, Kyaw BM, Kowatsch T, Joty S, Theng Y, et al. Conversational agents in health care: scoping review and conceptual analysis. J Med Internet Res 2020 Aug 07;22(8):e17158 (FREE Full text) (Medline: 32763886). [CrossRef]
- Gabarron E, Larbi D, Denecke K, Årsand E. What do we know about the use of chatbots for public health? Stud Health Technol Inform 2020 Jun 16;270:796-800. (Medline: 32570492). [CrossRef]
- Parmar P, Ryu J, Pandya S, Sedoc J, Agarwal S. Health-focused conversational agents in person-centered care: a review of apps. NPJ Digit Med 2022 Feb 17;5(1):21 (FREE Full text) (Medline: 35177772). [CrossRef]
- Oh KJ, Lee D, Ko B, Choi HJ. A chatbot for psychiatric counseling in mental healthcare service based on emotional dialogue analysis and sentence generation. 2017 Presented at: 8th IEEE International Conference on Mobile Data Management (MDM); May 29 - Jun 1; Daejeon, Korea p. 371-375 URL: https://ieeexplore.ieee.org/document/7962482. [CrossRef]
- Jovanovic M, Baez M, Casati F. Chatbots as conversational healthcare services. IEEE Internet Comput 2021 May;25(3):44-51 (FREE Full text). [CrossRef]
- He, L., Balaji, D., Wiers, R. W., Antheunis, M. L., & Krahmer, E. (2022). Effectiveness and acceptability of conversational agents for smoking cessation: a systematic review and meta-analysis. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, ntac281. Advance online publication. [CrossRef]
- Sasseville, M., Barony Sanchez, R. H., Yameogo, A. R., Bergeron-Drolet, L. A., Bergeron, F., & Gagnon, M. P. (2022). Interactive Conversational Agents for Health Promotion, Prevention, and Care: Protocol for a Mixed Methods Systematic Scoping Review. JMIR research protocols, 11(10), e40265. [CrossRef]
- Lachance, A., Yameogo, A. R., Plaisimond, J., Da, S., Bergeron, F., Sasseville, M., & Gagnon, M. (2023, February 10). Interactive conversational agents for cigarette smoking and vaping cessation: A protocol for a mixed-methods systematic scoping review. [CrossRef]
- Stern C, Lizarondo L, Carrier J, Godfrey C, Rieger K, Salmond S, et al. (2021). Methodological guidance for the conduct of mixed methods systematic reviews. JBI Evid Implement, 19(2), 120-129. [CrossRef]
- Selçuk AA. A guide for systematic reviews: PRISMA. Turk Arch Otorhinolaryngol 2019 Mar 10;57(1):57-58 (FREE Full text) (Medline: 31049257)2021;19(2):120-9. [CrossRef]
- Covidence. Veritas Health Innovation. URL: https://www.covidence.org/ (accessed 2022-10-03).
- Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021 Mar 29;372:n71 (FREE Full text) (Medline: 33782057). [CrossRef]
- Pluye P, Robert E, Cargo M, Bartlett G, O’Cathain A, Griffiths F, et al. Proposal: A Mixed Methods Appraisal Tool for systematic mixed studies reviews 2011. Available at http://mixedmethodsappraisaltoolpublic.pbworks.com. Accessed No-vember 15, 2013.
- Hong, Q. N., Pluye, P., Fàbregues, S., Bartlett, G., Boardman, F., Cargo, M., Dagenais, P., Gagnon, M. P., Griffiths, F., Nicolau, B., O’Cathain, A., Rousseau, M. C., & Vedel, I. (2019). Improving the content validity of the mixed methods ap-praisal tool: a modified e-Delphi study. Journal of clinical epidemiology, 111, 49–59.e1. [CrossRef]
- Abdullah AS, Gaehde S, Bickmore T. A Tablet Based Embodied Conversational Agent to Promote Smoking Cessation among Veterans: A Feasibility Study. J Epidemiol Glob Health. 31 déc 2018;8(3-4):225-30. [CrossRef]
- Alphonse A, Stewart K, Brown J, Perski O. Exploring Users’ Experiences With a Quick-Response Chatbot Within a Popular Smoking Cessation Smartphone App: Semistructured Interview Study. JMIR Form Res. 7 juill 2022;6(7):e36869. [CrossRef]
- Brown A, Kumar AT, Melamed O, Ahmed I, Wang YH, Deza A, et al. A Motivational Interviewing Chatbot With Generative Reflections for Increasing Readiness to Quit Smoking: Iterative Development Study. JMIR Ment Health. 17 oct 2023;10(1):e49132. [CrossRef]
- Haug S, Boumparis N, Wenger A, Schaub MP, Paz Castro R. Efficacy of a Mobile App-Based Coaching Program for Addiction Prevention among Apprentices: A Cluster-Randomized Controlled Trial. Int J Environ Res Public Health. janv 2022;19(23):15730. [CrossRef]
- He L, Basar E, Wiers RW, Antheunis ML, Krahmer E. Can chatbots help to motivate smoking cessation? A study on the effectiveness of motivational interviewing on engagement and therapeutic alliance. BMC Public Health. déc 2022;22(1):1-14. [CrossRef]
- Leeuwis L, He L. Hi, I’m Cecil(y) the Smoking Cessation Chatbot: The Effectiveness of Motivational Interviewing and Confrontational Counseling Chatbots and the Moderating Role of the Need for Autonomy and Self-efficacy. In: Følstad A, Araujo T, Papadopoulos S, Law ELC, Luger E, Goodwin M, et al., éditeurs. Chatbot Research and Design. Cham: Springer International Publishing; 2023. p. 3-17. [CrossRef]
- Olano-Espinosa E, Avila-Tomas JF, Minue-Lorenzo C, Matilla-Pardo B, Serrano MES, Martinez-Suberviola FJ, et al. Effectiveness of a Conversational Chatbot (Dejal@bot) for the Adult Population to Quit Smoking: Pragmatic, Multicenter, Controlled, Randomized Clinical Trial in Primary Care. JMIR MHealth UHealth. 27 juin 2022;10(6):e34273. [CrossRef]
- Perski O, Crane D, Beard E, Brown J. Does the addition of a supportive chatbot promote user engagement with a smoking cessation app? An experimental study. Digit Health. janv 2019;5:2055207619880676. [CrossRef]
- Do, H. P., Tran, B. X., Le Pham, Q., Nguyen, L. H., Tran, T. T., Latkin, C. A., Dunne, M. P., & Baker, P. R. (2018). Which eHealth interventions are most effective for smoking cessation? A systematic review. Patient preference and adherence, 12, 2065–2084. [CrossRef]
- Stead, L. F., Koilpillai, P., Fanshawe, T. R., & Lancaster, T. (2016). Combined pharmacotherapy and behavioural inter-ventions for smoking cessation. The Cochrane database of systematic reviews, 3(3), CD008286. [CrossRef]
- Lindson-Hawley N, Thompson TP, Begh R. Motivational interviewing for smoking cessation. Cochrane Database Syst Rev. 2015(3). [CrossRef]
- Gwaltney CJ, Metrik J, Kahler CW, Shiffman S. Self-Efficacy and Smoking Cessation: A Meta-Analysis. Psychol Addict Behav J Soc Psychol Addict Behav [Internet]. mars 2009 [cité 19 sept 2024];23(1). Disponible sur: https://www-ncbi-nlm-nih-gov.acces.bibl.ulaval.ca/pmc/articles/PMC3829471/. [CrossRef]
- Von Ah D, Ebert S, Ngamvitroj A, Park N, Kang DH. Factors Related to Cigarette Smoking Initiation and Use among College Students. Tob Induc Dis. 15 déc 2005;3(1):27. [CrossRef]
- Graham AL, Amato MS, Cha S, Jacobs MA, Bottcher MM, Papandonatos GD. Effectiveness of a Vaping Cessation Text Message Program Among Young Adult e-Cigarette Users: A Randomized Clinical Trial. JAMA Intern Med. 1 juill 2021;181(7):923. [CrossRef]
- Graham AL, Cha S, Jacobs MA, Amato MS, Funsten AL, Edwards G, et al. A Vaping Cessation Text Message Program for Adolescent E-Cigarette Users: A Randomized Clinical Trial. JAMA. 3 sept 2024;332(9):713-21. [CrossRef]
- Smit ES, Hoving C, Schelleman-Offermans K, West R, de Vries H. Predictors of successful and unsuccessful quit attempts among smokers motivated to quit. Addict Behav. sept 2014;39(9):1318-24. [CrossRef]
- Bendotti H, Lawler S, Ireland D, Gartner C, Marshall HM. Co-Designing a Smoking Cessation Chatbot: Focus Group Study of End Users and Smoking Cessation Professionals. JMIR Hum Factors. 19 août 2024;11(1):e56505. [CrossRef]
- Leung, T., Arnold, V., Reinfelde, M., Perski, O., Cummins, K., Whittaker, R., Dobson, R., & Garner, K. (2022). Chatbots for smoking cessation: scoping review. Journal of Medical Internet Research, 24(9). [CrossRef]

| Studies | Country | Year | Targeted behavior |
Study population | Participants | Technology name | Functionalities | Comparators | Study design |
|---|---|---|---|---|---|---|---|---|---|
| Abdullah et al., 2018 [34] | USA | 2018 | Tobacco smoking | Veterans receiving medical care at Boston VA Healthcare System |
6 | Embodied Conversational Agent (ECA) |
Audio, chat, avatar |
No comparators | Prospective cohort study |
| Alphonse et al., 2022 [35] | United Kingdom | 2022 | Tobacco smoking | Smokers aged ≥ 18 years | 14 | Quit Coach | Chat | No comparators | Semi-structured interview study |
| Brown et al., 2023 [36] | Canada | 2023 | Tobacco smoking | Current or recent smokers aged ≥ 18 years | 349 | MIBot | Chat | No comparators | Pre-post study |
| Haug et al., 2022 [37] | Switzerland | 2022 | Tobacco and e-cigarette smoking | Swiss teenagers aged 16-19 attending vocational schools | 688 | Ready4life | Chat, quiz | Participation in the program without Ready4life | Randomized controlled trial |
| He et al., 2022 [38] | Netherlands | 2022 | Tobacco smoking | Smokers aged ≥ 18 years | 153 | Roby | Chat | MI chatbot vs neutral chatbot |
Randomized between-subjects repeated measures trial |
| Leeuwis et al., 2023 [39] | Netherlands | 2023 | Tobacco smoking | Smokers aged ≥ 18 years | 233 | Cecily (MI chatbot condition) Cecil (confrontational counseling chatbot condition) |
Chat | Cecil (confrontational counseling chatbot condition) | Randomized controlled trial |
| Olano- Espinosa et al., 2022 [40] |
Spain | 2022 | Tobacco smoking | Smokers aged ≥ 18 years | 513 | Dejal@bot | Audio, chat, voice | Chatbot vs usual clinical practice |
Randomized clinical trial |
| Perski et al., 2019 [41] | UK | 2019 | Tobacco smoking | Smokers aged ≥ 18 years | 57 214 | Smoke Free (App) | Chat, voice | Smoke Free with supportive chatbot vs Smoke Free without chatbot |
Randomized community trial |
| Studies | Continuous abstinence |
Motivation to quit |
Engagement | Therapeutic alliance | Perceived empathy | Perceived communication competence |
Quality of life | Readiness to quit | Smoking/vaping reduction | Intention to quit |
|---|---|---|---|---|---|---|---|---|---|---|
| Brown et al., 2023 [36] | - | - | - | - | ✓ | - | - | ✓ | - | - |
| Haug et al., 2022 [37] | - | - | - | - | - | - | - | - | X | - |
| He et al., 2022 [38] | - | ✓ | 0 | 0 | 0 | ✓ | - | - | - | - |
| Leeuwis et al., 2023 [39] | - | - | - | - | - | - | - | - | - | X |
| Olano- Espinosa et al., 2022 [40] |
✓ | - | ✓ | - | - | - | ✓ | - | - | - |
| Perski et al., 2019 [41] | ✓ | - | ✓ | - | - | - | - | - | - | - |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).